Literature DB >> 9399402

Salmonellosis: an unusual complication of hepatocellular carcinoma.

T A Simmers1, G S Mijnhout, J J Van Meyel.   

Abstract

Salmonella abscess of a tumor is extremely rare, only three occurrences having been described to date. An unusual case is presented in which Salmonella infantis septicemia was the presenting symptom of multicentric hepatocellular carcinoma in a previously healthy 67-year-old man.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399402

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Spontaneous gas-forming liver abscess caused by Salmonella within hepatocellular carcinoma: a case report and review of the literature.

Authors:  Cheng-Chi Lee; Sek-Kwong Poon; Gran-Hum Chen
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

Authors:  John F Toso; Vee J Gill; Patrick Hwu; Francesco M Marincola; Nicholas P Restifo; Douglas J Schwartzentruber; Richard M Sherry; Suzanne L Topalian; James C Yang; Frida Stock; Linda J Freezer; Kathleen E Morton; Claudia Seipp; Leah Haworth; Sharon Mavroukakis; Donald White; Susan MacDonald; John Mao; Mario Sznol; Steven A Rosenberg
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

3.  First report of liver abscess caused by Salmonella enterica serovar Dublin.

Authors:  Fen Qu; Zhenping Fan; Enbo Cui; Wenjin Zhang; Chunmei Bao; Suming Chen; Yuanli Mao; Dongsheng Zhou
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

4.  An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth.

Authors:  T Liu; A K Chopra
Journal:  Cancer Gene Ther       Date:  2009-08-28       Impact factor: 5.987

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.